scispace - formally typeset
C

Cynthia R. Cherry

Researcher at East Carolina University

Publications -  20
Citations -  385

Cynthia R. Cherry is an academic researcher from East Carolina University. The author has contributed to research in topics: Lung cancer & Nivolumab. The author has an hindex of 5, co-authored 18 publications receiving 232 citations.

Papers
More filters
Journal ArticleDOI

Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.

TL;DR: Tocilizumab may be a therapeutic option for the management of steroid refractory irAEs secondary to immune checkpoint blockade, however, randomized trials are needed to better elucidate the relative efficacy and safety of these agents.
Journal ArticleDOI

Antibiotic use and overall survival in lung cancer patients receiving nivolumab.

TL;DR: The gut microbiome modulates immunotherapy responses in multiple tumor types and some studies report antibiotics (ATB) may alter the microbiota composi...
Journal ArticleDOI

Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting.

TL;DR: NLR and CRP were significantly elevated at the time of MACE compared to baseline values in ICI-treated patients, and larger datasets are needed to validate these findings and identify predictors of Mace that can be used in the diagnosis and management of ICi-related iRC.